Stay updated on Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with a standard error page. This blocks access to the study details and related information on the page.
    Difference
    18%
    Check dated 2026-09-20T19:53:51.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a minor site version bump.
    Difference
    0.1%
    Check dated 2026-08-30T22:38:08.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.6.4 to v3.6.5. This indicates a minor platform update applied to the page without changing study content or public-facing information.
    Difference
    0.1%
    Check dated 2026-08-09T08:21:29.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, reflecting a new release of the page template. This update does not modify the study details or other substantive content.
    Difference
    0.1%
    Check dated 2026-07-25T18:46:47.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3. This denotes a small behind-the-scenes update to the page version; no study content was altered.
    Difference
    0.1%
    Check dated 2026-07-04T13:29:58.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page’s revision label at the bottom updated from v3.6.0 to v3.6.2. This reflects a backend or template update of the page, not changes to the study information displayed.
    Difference
    0.1%
    Check dated 2026-06-27T06:15:42.000Z thumbnail image

Stay in the know with updates to Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.